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Abstract.  28 
Bovine Digital Dermatitis (BDD), an infectious disease of the bovine foot with a predominant 29 
treponemal aetiology, is a leading cause of lameness in dairy and beef herds worldwide. BDD 30 
is poorly responsive to antimicrobial therapy and exhibits a relapsing clinical course; an 31 
effective vaccine is therefore urgently sought. Using a ‘reverse vaccinology’ approach, the 32 
present study surveyed the genomes of the three BDD-associated Treponema phylogroups 33 
for putative β-barrel outer membrane proteins and considered their potential as vaccine 34 
candidates. Selection criteria included the presence of a signal peptidase I cleavage site, a 35 
predicted β-barrel fold and cross-phylogroup homology. Four candidate genes were 36 
overexpressed in Escherichia coli BL21 (DE3), refolded and purified. Consistent with their 37 
classification as β-barrel OMPs, circular dichroism spectroscopy revealed the adoption of a 38 
predominantly β-sheet secondary structure. These recombinant proteins, when screened for 39 
their ability to adhere to immobilised ECM components, exhibited a diverse range of ligand 40 
specificities. All four proteins specifically and dose-dependently adhered to bovine fibrinogen. 41 
One recombinant protein was identified as a candidate diagnostic antigen (disease specificity, 42 
75%). Finally, when adjuvanted with aluminium hydroxide and administered to BDD-naïve 43 
calves using a prime-boost vaccination protocol, these proteins were immunogenic, eliciting 44 
specific IgG antibodies. In summary, we present the description of four putative treponemal 45 
β-barrel OMPs that exhibit the characteristics of multispecific adhesins. The observed 46 
interactions with fibrinogen may be critical to host colonisation and dissemination and it is 47 
hypothesised that vaccination-induced antibody blockade of these interactions will impede 48 
treponemal virulence and thus be of therapeutic value.  49 
 50 
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 60 
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Introduction.  61 
Bovine digital dermatitis (BDD) is a painful, ulcerative disease of the bovine foot and a 62 
significant cause of lameness in dairy cattle. Clinically, BDD presents as a malodorous, focally-63 
inflamed, circumscribed lesion of raised hyperkeratotic skin localised to the plantar/palmer 64 
aspect of the interdigital cleft, on or adjacent to the coronary band (1, 2). BDD is now 65 
considered to be the most common infectious cause of lameness in dairy cattle herds in the 66 
northern hemisphere and one of the most significant challenges to farm animal welfare. 67 
Moreover, the economic burden to the dairy industry resulting from production losses is 68 
considerable (3). In the UK, BDD is endemic, affecting an estimated 79% of UK dairy farms (4), 69 
and emergence of BDD in beef herds has also been recently described (5, 6). In addition, a 70 
new variant (contagious ovine digital dermatitis), noted for its particularly severe 71 
presentation in sheep, continues to spread through the UK’s national flock (7, 8). This disease 72 
therefore represents an additional and growing challenge to global food security.  73 
 A substantial body of evidence supports the involvement of multiple Treponema spp. at 74 
various stages of BDD lesion development (9–12). Three treponeme taxa in particular have 75 
been consistently isolated from lesion biopsy material from cases in the US and the UK, 76 
namely the Treponema medium phylogroup, the Treponema phagedenis phylogroup and 77 
Treponema pedis (13, 14). The presence of these organisms deep within the lesion (15, 16), 78 
their clear association with necrotic changes in infected tissue (17), a failure to isolate these 79 
organisms from the feet of healthy animals (12, 18) and a disease-associated, specific IgG 80 
antibody response to these organisms (19–23) strongly implies an aetiopathogenic role in 81 
BDD.  82 
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Treponemes are gram-stain-negative bacteria exhibiting a spiral morphology and consist of 83 
an outer membrane (OM) that surrounds the axial filaments and the protoplasmic cylinder 84 
(24). The OM of these extracellular pathogens is a feature of considerable interest, given its 85 
surface exposure and the subsequent involvement of its components in host-pathogen 86 
interactions. Adhesins embedded in the OM play a critical role in bacterial cytoadherence to 87 
the host during colonisation. The host extracellular matrix (ECM) is an important adherence 88 
target for pathogenic microorganisms during the primary stages of infection. Previous studies 89 
investigating the ECM binding capacity of the two most relevant human pathogenic species, 90 
T. pallidum sub. pallidum, the causative agent of syphilis, and Treponema denticola, a key 91 
member of the polymicrobial consortium implicated in periodontal disease, reported specific 92 
treponemal cell adherence to a range of immobilised ECM components, including fibronectin, 93 
laminin, fibrinogen and collagen (25, 26). Subsequently, a growing number of adhesins are 94 
being identified and investigated to characterise the molecular basis of physical host-95 
pathogen interactions (27–35). However, the fastidious nature of the BDD-associated 96 
treponemes has precluded any detailed characterisation of the OM components likely to 97 
promote such interactions. Employing recently available BDD-associated treponeme genome 98 
sequences, we sought to identify novel β-barrel OMP-encoding genes and characterise the 99 
function of the recombinantly expressed OMPs in ECM binding assays.    100 
METHODS.  101 
Ethical approval.  102 
All experimental work involving animals was covered by a UK Home Office Project License PPL 103 
70/8330.  104 
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In silico identification of Outer Membrane Proteins (OMPs).  105 
Previously generated and annotated representative genomes of the three BDD treponemes, 106 
T. medium T19 (Accession CP027017), T. phagedenis T320A (Accession CP027018) and T. pedis 107 
T3552BT (Accession CP045760) were subjected to in silico analysis to identify putative OMPs 108 
via prediction of encoded β-barrel structural motifs. Putative Coding Sequence (CDS) features 109 
for each genome were translated to their amino acid sequences using Artemis (36). All 110 
translated T. medium T19 CDS features were analysed for the presence of a signal peptidase 111 
I cleavage site using SignalP 4.1 (37). Sequences predicted to harbour a signal peptide were 112 
further scrutinised for signatures of β-barrel tertiary structure using three β-barrel prediction 113 
programs (BOMP (38), TMBETA-NET (39) and PRED-TMBB (40)). All T. medium T19 CDS 114 
features which were predicted to code a β-barrel tertiary structured protein by at least one 115 
of the β-barrel prediction programs were retained. Homologues of putative T. medium T19 116 
OMPs were identified in T. phagedenis T320A and T. pedis T3552BT genomes using a 117 
combination of a Markov cluster algorithm (41) and BLAST (42) and their OMP predictions 118 
verified independently. Putative OMP sequences which were conserved in all three genomes 119 
were examined for predicted adhesin functionality using SPAAN (43) and their tertiary 120 
structures modelled using I-TASSER (44).  121 
Cloning and expression of candidate antigens.  122 
T. medium T19, T. phagedenis T320A and the T. pedis T3552BT, isolated previously from BDD 123 
lesion biopsies (12, 14) and cryopreserved in 10% (v/v) glycerol at -80 oC, were cultured as 124 
described previously (12). Genomic DNA (gDNA) was extracted from the treponeme cultures 125 
at late exponential phase using Chelex® 100 resin (Bio-Rad Laboratories Ltd, Hemel 126 
Hempstead, UK) according to a previously described method (45). The Gateway System (Life 127 
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Technologies, Paisley, UK) was utilised for gene cloning and expression. Putative OMP 128 
sequences, lacking their signal peptide sequences, were amplified from the gDNA using high-129 
fidelity Phusion polymerase (Thermo Scientific, Hemel Hempstead, UK) in accordance with 130 
manufacturer instructions. Primers (Table 1) for amplification contained CACC overhangs to 131 
facilitate entry cloning. A well-characterised OMP (OmpL1) from Leptospira interrogans 132 
serovar Copenhageni strain M20 was selected (46–48) and produced as a recombinant 133 
protein control.  134 
Amplified putative OMPs were inserted into the Gateway entry plasmid pENTR™/D-TOPO™ 135 
(Life Technologies, Paisley, UK) in accordance with the manufacturer’s instructions prior to 136 
chemical transformation into Escherichia coli Top10 cells. Positive transformants were 137 
selected on LB agar plates containing kanamycin (50 µg/ml) and plasmid DNA from successful 138 
transformants isolated using the Qiagen Plasmid MiniPrep Kit (Qiagen, Manchester, UK). 139 
Successful amplicon insertion was confirmed using EcoRV restriction digest analysis 140 
(ThermoFisher, Horsham, UK). Inserts were thereafter cloned into the Gateway expression 141 
vector, pDEST™17, using a site-directed integration reaction in accordance with the 142 
manufacturer’s instructions (Life Technologies, Paisley, UK) prior to chemical transformation 143 
into DH5α E. coli. Positive transformants were selected on LB agar plates containing ampicillin 144 
(100 µg/ml) and the plasmid DNA isolated as previously described. pDEST™17-gene 145 
constructs verified by EcoRI endonuclease restriction digest analysis and Sanger sequencing 146 
(Source Bioscience, Nottingham, UK). 147 
Protein expression, refolding and purification 148 
All protein expression was performed in E.coli BL21 DE3 (Life Technologies, Paisley, UK). E.coli 149 
BL21 DE3 cultures were grown at 37oC with shaking in LB medium (2 L) containing ampicillin 150 
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(100 µg/ml), until the OD600 was 0.8-1. Protein expression was induced by the addition of 1 151 
mM IPTG (Sigma Aldrich, Gillingham, UK). Cultures were grown for a further 4-5 hours and 152 
cells harvested by centrifugation (3500 x g, 4oC, 10 mins). E. coli BL21 DE3 cell pellets were 153 
re-suspended in 50 mM Tris-HCl pH 7.9 (20ml per 10 g wet cell weight) containing lysozyme 154 
(5 mg/g wet cell weight) (Sigma Aldrich, Gillingham, UK) and incubated on ice for 30 min prior 155 
to cellular disruption using a micro-sonicator tip (Soniprep-150, MSE, London, UK). Inclusion 156 
bodies (IB) containing recombinant proteins were subsequently harvested by centrifugation 157 
(10000 x g, 4oC, 30 mins). IB pellets were re-suspended in 150 ml of IB detergent buffer (4% 158 
(v/v) Tergitol™ 15-S-9 (Sigma-Aldrich, Dorset, UK), 50 mM Tris HCl, pH 7.9) with rapid stirring 159 
for a minimum of two hours, washed twice in 150 ml IB wash buffer (50 mM Tris HCl, pH 7.9) 160 
and re-suspended in solubilisation buffer (6M Guanidine hydrochloride, 50 mM Tris-HCl pH 161 
7.9 and 1 mM EDTA; 40 ml per 500 mg of IB) for 1 hour with constant agitation. The 162 
suspension was centrifuged (10, 000 x g, 4oC, 30 mins) to remove insoluble material. 163 
Recombinant protein refolding was performed by rapid dilution (49) into refolding buffer (250 164 
mM NaCl, 50 mM Tris-HCl pH 7.9, 5% N,N-Dimethyldodecylamine N-oxide solution (LDAO; 165 
Sigma-Aldrich, Dorset UK)) and subsequently dialysed against 10 volumes of dialysis buffer 166 
(250 mM NaCl, 50 mM Tris-HCl pH 7.9, 0.1% LDAO). Refolded, recombinant proteins were 167 
purified by standard immobilised metal affinity chromatography (50), sterilised through a 0.2 168 
µM filter and stored at -80oC. The purity of the recombinant proteins was assessed by SDS-169 
PAGE.  170 
Evaluation of secondary structure.  171 
Heat modifiability. The sensitivity of the recombinant proteins to denaturation upon heating 172 
was determined by comparing the electrophoretic mobility of the refolded recombinant 173 
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proteins prepared in SDS sample buffer without reducing agent (100mM Tris-HCl [pH 6.8] 4% 174 
(w/v) SDS, 0.2% (w/v) bromophenol blue, 20 % (v/v) glycerol) and either incubated at ambient 175 
temperature for 10 minutes or heated to 100oC for 10 minutes prior to SDS-PAGE analysis, as 176 
described previously (51).  177 
Circular dichroism (CD) spectroscopy. Far UV CD spectroscopy was performed using a Jasco J-178 
810 spectropolarimeter (Japan Spectrocopic, Tokyo, Japan), equipped with a Peltier unit for 179 
temperature control. Spectra were measured from 190 to 260 nm using 1-mm path length 180 
cell at intervals of 0.5-nm and presented as an average of three scans. Spectra were analysed 181 
by Beta Structure Selection (BestSel) software (http://bestsel.elte.hu/) (52) to calculate the 182 
percentage secondary structure content from the ellipticity experimental data. 183 
Evaluation of immunogenicity during natural infection.  184 
Cattle sera 185 
An ELISA was performed to investigate systemic IgG seroreactivity to the putative OMPs in 186 
blood samples collected from cows naturally infected with BDD. Sera from sixteen adult 187 
Holstein-Friesian cows with a recent (<6 month) history of BBD, were collected from a dairy 188 
herd situated in Cheshire, UK. Similarly, sera from 5 healthy adult Holstein-Friesian cows were 189 
collected from a closed dairy herd situated in Monmouthshire, UK, and were included as a 190 
control group. In all cases, whole blood was collected from the coccygeal vein. Following 191 
clotting and centrifugation, the serum fraction was harvested and stored at -20oC for 192 
serological assessment. 193 
Serological ELISA 194 
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Non-activated, 96-well microtitre plates (Microplate Immulon 2HB, Thermo Scientific, Hemel 195 
Hempstead) were coated with a single recombinant protein (5 μg/ml) in PBS (pH 7.2) and 196 
incubated for 1 hour (37oC) and overnight (4oC). Unbound antigen was removed by washing 197 
with PBST (PBS-Tween 20; 0.05%). All sera were diluted 1/100 in PBST and pipetted into ELISA 198 
plate wells in duplicate and incubated for 1 hour (37oC). Wells were washed as before and 199 
incubated for 1 hour (37oC) with 100 μl monoclonal mouse anti-bovine immunoglobulin class 200 
G subclass 1 (IgG1) antibody, clone IL-A60 (BioRad, Hemel Hempstead, UK) or monoclonal 201 
mouse anti-bovine immunoglobulin class G subclass 2 (IgG2) antibody, clone IL-A2 (BioRad, 202 
Hemel Hempstead, UK), diluted 1:1000. To ensure adherence of the antigen to the plate, 100 203 
μl of mouse monoclonal anti-polyhistidine antibody, clone HIS-1 (Sigma-Aldrich, Dorset, UK), 204 
diluted 1:2000 in PBST, was added to recombinant control wells. Following washing, wells 205 
were incubated with 100 μl of horse-radish peroxidase (HRP)-conjugated goat anti-mouse IgG 206 
antibodies (Sigma-Aldrich, Dorset, UK), diluted 1:10000 in PBST for 1 hour (37oC). Following 207 
washing, the presence of HRP-conjugated goat anti-mouse IgG antibodies was detected by 208 
the addition of 100 μl of the HRP substrate, 3,3′,5,5′-Tetramethylbenzidine (TMB) (Sigma-209 
Aldrich, Dorset, UK). The reaction was terminated after ~20 minutes by the addition of 100 μl 210 
0.5 M hydrochloric acid. The optical density (OD) of each well was read at 450 nm using a 211 
microplate reader (Multiskan EX; Thermo Fisher Scientific, Loughborough, UK). All data was 212 
processed and analysed using GraphPad Prism 5 (GraphPad, San Diego, CA). In order to 213 
classify results as positive or negative, an ELISA OD value of less than or equal to the mean 214 
plus 3 standard deviations of the control sera was considered to be non-reactive (53). 215 
Evaluation of adhesin function.  216 
ECM macromolecules.  217 
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All ECM macromolecules were purchased from Sigma Aldrich (Dorset, UK), and prepared from 218 
the following sources: Collagen I from bovine skin; elastin from bovine neck filament; 219 
fibrinogen from bovine plasma; heparan sulphate from bovine kidney; chondroitin sulphate 220 
from bovine cartilage; laminin-1 from the basement membrane of Engelbreth-Holm-Swarm 221 
mouse sarcoma.  222 
ECM-binding ELISA. 223 
An ELISA was performed to screen the recombinant proteins for their ability to attach to 224 
individual ECM macromolecules using a previously described method (54). Briefly, Immulon 225 
2HB plates (ThermoFisher, Horsham, UK) were coated with 5 μg/ml of the ECM component 226 
or the negative control protein (BSA) by incubation for 1 hour at 37oC and overnight at 4oC, 227 
washed with PBS containing 0.05% Tween 20 (PBST) and blocked with a 1% (w/v) BSA 228 
solution. Recombinant proteins, diluted in PBST, were added at 10 µg/ml to screen for ECM 229 
binding activity and a range of concentrations (from 0 to 6 µM) to determine the dose-230 
dependency of these binding interactions. Following incubation, bound recombinant proteins 231 
were detected by addition of mouse monoclonal anti-polyhistidine IgG antibody (Sigma-232 
Aldrich, Dorset, UK), diluted 1:2000, before proceeding as described before. KD values were 233 
estimated from curves fitted by non-linear regression analysis in GraphPad Prism v. 5, using 234 
the following equation: KD = (Amax [protein])/A) – [protein], where A is the absorbance at a 235 
given protein concentration, Amax is the maximum plate reader absorbance (when the 236 
equilibrium is reached), [protein] is the protein concentration and KD is the dissociation 237 
equilibrium constant (55, 56).  238 
Far-western blotting.  239 
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A far-western blotting technique was employed to further characterise the specific binding 240 
interactions between the recombinant proteins and bovine fibrinogen (57). To dissociate 241 
native bovine fibrinogen into its constituent polypeptide chains (Aα, Bβ and γ), 60 μl of bovine 242 
fibrinogen stock solution (1 mg/ml) was mixed with 350 μl of gel loading buffer (100 mM Tris-243 
Cl [pH 6.8] 4% SDS, 0.2% bromophenol blue, 20 % glycerol, 200 mM dithiothreitol, heated at 244 
95oC for 5 minutes and separated in Tris-glycine polyacrylamide gels by SDS-PAGE (4-20 % 245 
gradient gel) at a constant voltage of 180 V for 50 minutes. The fibrinogen chains were 246 
electroblotted onto a nitrocellulose membrane (100 V, 240 mA, 120 minutes) and the 247 
membrane was blocked with 5% (w/v) skimmed milk. Membranes were subsequently 248 
incubated with 30 μg/ml recombinant protein. Any bound protein was detected by incubation 249 
of the membrane with mouse anti-polyhistidine antibody (Sigma-Aldrich, Dorset, UK), diluted 250 
1:2000 followed by goat anti-mouse antibody (Sigma-Aldrich, Dorset, UK) and development 251 
in 3,3′-diaminobenzidine membrane substrate (Sigma-Aldrich, Dorset, UK). 252 
Immunogenicity trial in calves.  253 
Calves.  254 
The immunogenicity of the recombinant proteins was evaluated in two Holstein-Friesian 255 
calves. A control group of two additional calves was used to verify that any serological 256 
response did not result from environmental exposure to BDD-associated treponemes or to 257 
ubiquitous antigens.  258 
The four calves were reared and maintained according to routine agricultural practice at the 259 
University’s Farm with housing conditions having increased biosecurity to reduce the risk of 260 
exposure to the BDD-associated Treponema spp.. Calves were bedded on straw and 261 
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quarantined for 4 weeks before vaccine administration. Calves were bled immediately prior 262 
to vaccine administration to ascertain pre-immunisation antibody status.  263 
Formulation of the vaccine.  264 
The multivalent vaccine was formulated to deliver the four recombinant proteins 265 
simultaneously and comprised of 100 µg of each recombinant protein and 40 µl aluminium 266 
hydroxide adjuvant (Rehydragel®, Chemtrade Logistics, Toronto, Ontario), adjusted to a final 267 
volume of 2 ml using PBS. All vaccines were administered subcutaneously to the left flank. 268 
Calves received an initial 2 ml dose of the vaccine followed by a 2 ml booster dose two weeks 269 
later. Concurrently, Control animals (n=2) received a 2 ml dose of the vehicle only. Blood 270 
samples, obtained by jugular venepuncture, were collected at two-week intervals for four 271 
weeks beginning with a pre-immunisation draw at day zero. Serum was retained for 272 
serological studies. 273 
Detection of serum IgG antibodies by ELISA.  274 
Vaccinee IgG1 and IgG2 antibody seroreactivity to the recombinant proteins was determined 275 
as described previously in this manuscript. All data was processed and analysed using 276 
GraphPad Prism 5 (GraphPad, San Diego, CA). ELISA reactivity was confirmed by Western blot 277 
analysis using previously described methods (23).  278 
RESULTS.  279 
In silico detection of putative treponemal OMPs.  280 
SignalP 4.1 analysis identified 182 T. medium T19 CDS features predicted to contain an N-281 
terminal peptidase I cleavage site. These features were further analysed by three β-barrel 282 
prediction programs: BOMP, PRED-TMBB and TMBETA-NET. CDS features predicted to 283 
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encode β-barrel proteins by at least one these programs were selected for cross-phylogroup 284 
homology detection.  In total, fifteen CDS features identified in the T. medium T19 genome 285 
matched the following selection criteria precisely: i) the presence of a signal peptidase I 286 
cleavage site, ii) a predicted β-barrel topology and iii) cross-phylogroup homology (Table 2). 287 
Four CDS features, two from the T. medium genome and two from the T. pedis genome 288 
(including one homologous pair: C5N99_10335 and DYQ05_13425; amino acid sequence 289 
identity 31.87%) were subsequently selected to evaluate their ability to bind to selected ECM 290 
components and to induce an IgG antibody response in calves.  291 
Prediction of 3-dimensional (3D) tertiary structure.  292 
To generate predicted 3D structural models, each protein sequence was submitted to the I-293 
TASSER server. The highest-ranking model for each protein is shown in Fig. 1. The four 294 
putative OMPs were each predicted to contain a typical β-barrel domain, consistent with 295 
localisation to the outer membrane of gram-negative bacteria.  296 
Typical β-barrel structures were predicted for C5N99_10335, DYQ05_13425 and 297 
DYQ05_06810, whereas C5N99_02965 was predicted to adopt a β-solenoid fold.  298 
Heat-modifiability assay. 299 
Three of the proteins expressed a heat-modifiable electrophoretic mobility, consistent with 300 
the stability of a protein comprising predominantly of a β-structure (66). Fig. 2 shows the 301 
change in electrophoretic mobility observed under unheated versus heated conditions for 302 
C5N99_10335, C5N99_02965 and DYQ05_06810.  303 
Heat modification of C5N99_02965 (Fig. 2A) led to a change in electrophoretic mobility and a 304 
change in the apparent MW, from ~30 to ~ 36 kDa. Similar changes in mobility were observed 305 
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for C5N99_10335 (Fig 2B; ~22 to ~24 kDa) and DYQ05_06810 (Fig 2C; ~21 to 23 kDa). Heat 306 
modifiability was not identified for DYQ05_13425 (data not shown).  307 
CD spectroscopic analysis of the treponemal recombinant OMP secondary structure.  308 
Far UV CD spectroscopy was employed to provide further evidence of the secondary structure 309 
fold of these proteins (Fig. 3). Consistent with a predicted β-barrel tertiary structure state, 310 
analysis of the four putative OMPs yielded spectral signatures typical of a predominantly β-311 
sheet secondary structure, with spectral minima occurring at approximately 218 nm for 312 
C5N99_10335, C5N99_02965, DYQ05_06810 and DYQ05_13425 as well as the positive 313 
control protein, OmpL1.  314 
Serological response to putative OMPs during natural BDD infection.  315 
 316 
As demonstrated in Fig 4, IgG2 seroreactivity to DYQ05_06810 was detected in BDD-infected 317 
Holstein Friesian cows (n=12; 75%) relative to the healthy control animals, with no apparent 318 
IgG2 response observed against the remaining three putative OMPs. No IgG1 response was 319 
identified against any of the putative OMPs under investigation. A statistically significant 320 
decrease in the IgG1 ELISA ODs was observed in the sera of BDD-exposed animals, relative to 321 
controls, in the T. medium/T19 putative OMP analyses (P<0.05).  322 
Binding of the treponemal OMPs to ECM components.  323 
Statistically significant (P<0.05) adherence to fibrinogen, elastin and heparan sulphate was 324 
observed for both C5N99_10335 and C5N99_02965, with C5N99_10335 additionally adhering 325 
to fibronectin (Fig. 5).  326 
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The T. pedis homologue of C5N99_10335, namely DYQ05_13425, exhibited a similar binding 327 
profile to C5N99_10335, but was found to additionally bind to chondroitin. DYQ05_06810 328 
bound to fibronectin, fibrinogen, elastin, chondroitin and heparan sulphate. 329 
Next, given the ubiquitous fibrinogen binding amongst these putative treponemal OMPs (P 330 
<0.01), we sought to further characterise this interaction across a concentration range. The 331 
results of these analyses are shown in Fig. 6. 332 
The binding interactions between fibrinogen and C5N99_10335, C5N99_02965, 333 
DYQ05_06810 and DYQ05_13425 were observed to be concentration-dependent. Binding 334 
saturation levels were achieved with recombinant protein concentrations of ~1 µM, ~1.5 µM, 335 
and ~2.0 µM for C5N99_02965, DYQ05_13425 and DYQ05_06810, respectively. Conversely, 336 
C5N99_10335, although showing a tendency towards reaching saturation, failed to do so up 337 
to a concentration of 2 µM. Further examination of this interaction was precluded by 338 
insufficient protein yield. KD values were estimated by non-linear regression analysis of the 339 
binding curves. Table 4 summarises the KD values calculated from these experiments. The 340 
positive control protein, OmpL1, was similarly observed to adhere to bovine fibrinogen in a 341 
dose-dependent and saturable manner as previously reported (47) (data not shown).  342 
Far western blotting.  343 
Far Western blotting identified interactions between the putative OMPs and individual chains 344 
of the fibrinogen molecule. The results of this analysis are shown in Fig. 7. 345 
The results of the far western analysis revealed that DYQ05_13425 and DYQ05_06810 346 
interacted with all three chains of the fibrinogen molecule, similarly to OmpL1. Conversely, 347 
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C5N99_10335 and C5N99_02965 were observed to interact with the β and γ chains of 348 
fibrinogen only.  349 
Immunogenicity.  350 
The immunogenic properties of these four fibrinogen-binding proteins were investigated 351 
following inoculation into two naïve bull calves as part of a multivalent antigen cocktail. ELISA 352 
analysis of pre-vaccination sera yielded broadly comparable ELISA ODs between calves. 353 
This pilot immunogenicity trial demonstrated that this subcutaneous prime-boost vaccination 354 
protocol, involving an aluminium hydroxide-adjuvanted 100 µg dose of each treponemal 355 
recombinant OMP, is capable of eliciting IgG antibodies in BDD-naïve bull calves (Fig. 8). All 356 
animals vaccinated with the recombinant protein cocktail seroconverted rapidly, permitting 357 
treponemal OMP-specific IgG antibody detection by day 14. A second booster vaccination on 358 
day 14 enhanced the IgG response further and specific antibody titres peaked at day 28. No 359 
seroconversion was detected in the control animals up to day 56 (the last day of the trial; data 360 
not shown). The fold-change, calculated as the mean OD change on day 28 from pre-361 
immunisation baseline (Table 5) was used to account for varying baseline ELISA ODs.  362 
Whilst all recombinant proteins were shown to be immunogenic under the conditions of this 363 
trial, C5N99_10335 was found to be the weakest driver of both an IgG1 and IgG2 antibody 364 
response, with ELISA OD fold changes calculated to be 2.37 and 1.66 from baseline, 365 
respectively. DYQ05_13425, conversely, was found to the most potent immunogen, with 366 
ELISA OD fold-changes from baseline calculated to be 7.44 and 9.10, for IgG1 and IgG2, 367 
respectively. The specificity of the anti-sera was confirmed using Western Blotting and 368 
revealed the presence of treponemal putative OMP-specific IgG1 and IgG2 serum antibodies 369 
in immunised animals only (data not shown). Serological analysis on day 42 of the trial 370 
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revealed a slight waning of the IgG antibody response in all cases. The trial vaccine was well 371 
tolerated in vaccinated calves.  372 
DISCUSSION.  373 
Using a bioinformatics-based approach, the present study sought to identify and characterise 374 
novel BDD-associated treponemal OMPs, bearing in mind the potential value of these 375 
molecules as BDD vaccine candidates. Post-purification analysis of the four refolded proteins 376 
by CD spectroscopy yielded spectra indicative of a predominantly β-strand secondary 377 
structure with three of the proteins (C5N99_10335, C5N99_02965 and DYQ05_06810) 378 
additionally demonstrated to be heat-modifiable. These findings are consistent with the 379 
characteristics of proteins with a β-barrel tertiary structure. Conversely, DYQ05_13425 was 380 
found to not be heat-modifiable. Owing to a highly resistant tertiary-structure, some bacterial 381 
OMPs exhibit an unusual stability to heat in the presence of SDS and an extended heating 382 
period may be required to convert such proteins to their denatured form, as reported for 383 
Protein F from P. aeruginosa  (67) and OmpL1 from L. interrogans (66). 384 
Examination by ELISA of IgG seroreactivity in animals naturally infected with BDD revealed 385 
that only one protein (DYQ05_06810) was capable of discriminating clearly between the sera 386 
of animals with recent or active BDD infection and cattle presumed not to have been exposed 387 
to the BDD treponemes. In identifying a disease-specific IgG2 antibody response to 388 
DYQ05_06810, these findings are in concordance with the findings of a number of previous 389 
studies that demonstrated a strong anti-treponemal IgG2 bias in the antibody response of 390 
animals naturally infected with BDD (68–70). These data suggest that whilst DYQ05_06810 is 391 
accessible to the immune system during treponemal infection (and thus capable of eliciting 392 
IgG2 antibodies), the remaining three putative treponemal OMPs may be expressed as 393 
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subdominant antigens or their expression may be immunosubversive in nature. 394 
Unexpectedly, a reduction in OD was observed when comparing the IgG1 response to the two 395 
T. medium/T19 putative OMPs in cows exposed to BDD relative to healthy controls. The 396 
reasons for this are unclear, although treponemes exhibit a number of immunosuppressive 397 
functions capable of interfering with both innate (71) and adaptive immune activity (72), the 398 
utilisation of which is likely to contribute to infection chronicity. In this case, it is speculated 399 
that whereas previous colonisation with bacteria expressing orthologues of C5N99_10335 400 
and C5N99_02965 leads to the production of cross-reactivity antibodies (which are 401 
detectable in control animals), subsequent infection with T. medium leads to a reduction in 402 
the serotitre of these antibodies via immunosuppressive mechanisms. Crucially, both proteins 403 
have been detected in the transcriptome of BDD lesions (73) and studies are required to 404 
investigate their capacity to modulate host immunity.  405 
Presently, no commercially available serological assay to detect BDD treponemes is available 406 
for field diagnostics and immunoassay-based serological assessment of BDD in research 407 
settings is currently dependent on the use of whole cell lysates. The T. phagedenis putative 408 
proline-rich repeat lipoprotein, PrrA, was previously identified as an immunogenic protein of 409 
T. phagedenis-like strain V1 (isolated from a BDD lesion) and as an antigenic target capable of 410 
discriminating between animals acutely infected with BDD (n=8) and BDD naïve animals (n=7) 411 
(74). An ELISA, capable of detecting bovine anti-PrrA antibodies in serum and milk, has been 412 
available to the research community for some time, although there are currently no reports 413 
detailing post-marketing experience. In addition, the PrrA gene and its product have been 414 
absent from several T. phagedenis-like BDD lesion isolates (74, 75), potentially limiting the 415 
value of this ELISA as a means of determining herd infection status. It is therefore proposed 416 
that the IgG2 antibody response to DYQ05_06810 be further evaluated as a potential 417 
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antigenic marker of seroconversion in BDD-infected animals. The diagnosis of BDD currently 418 
remains restricted to clinical examination of the lifted foot by means of individual restraint 419 
(76) and specificity and sensitivity are limited by subjectivity and observer-bias (77). A 420 
quantitative diagnostic ELISA is less labour-intensive, less time consuming, and is a more 421 
reproducible indicator of biological infection (78). Since these recombinant molecules can be 422 
readily synthesised in E. coli expression systems, the difficulties in cultivating BDD-associated 423 
Treponema spp. for whole-cell antigen preparations are bypassed.   424 
An initial ECM binding screen demonstrated that the putative treponemal β-barrel OMPs 425 
identified in this study exhibited ECM-adhesive properties, supporting their role in bacterial 426 
cytoadherence to host tissues. Interestingly, these proteins exhibited multispecific ECM 427 
binding profiles. One of the most striking properties of the putative treponemal OMPs was an 428 
ability to adhere to immobilised bovine fibrinogen. Because of the highly significant nature of 429 
this interaction, these fibrinogen binding activities were investigated further and found to be 430 
concentration-dependent and saturable, suggesting the existence of fibrinogen-specific 431 
binding sites. The estimated dissociation constants (KD) (0.34 and 0.72 for C5N99_02965 and  432 
DYQ05_13425, respectively) broadly align with those calculated for other spirochaetal 433 
fibrinogen binding proteins, including the leptospiral proteins OmpL1 (0.223 µM) (47), 434 
OmpL37 (0.244 µM) (79) and Lsa33 (0.12 µM) (80), supporting the relevance of these 435 
interactions in vivo. DYQ05_06810 exhibited a higher estimated KD of 1.0 µM, and is of a 436 
similar magnitude to other biologically-relevant ECM binding interactions, including those 437 
reported for OmpL1 interactions with laminin (KD = 2.10 µM) and fibronectin (KD = 1.24 µM) 438 
(46).  439 
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Bovine fibrinogen is a 340-kda dimeric glycoprotein comprising of three pairs of non-identical 440 
Aα (~67 kDa), Bβ (~55 kDa) and γ (~48 kDa) peptide chains. Fibrinogen is a major clotting 441 
factor and performs an essential role in preventing haemorrhage and facilitating vascular 442 
repair. At sites of tissue damage, fibrinogen is found embedded with the extracellular matrix 443 
(81). It has previously been demonstrated that successful and consistent experimental 444 
transmission of BDD requires abrasion of the skin (82). Abrasive trauma would be expected 445 
to lead to enhanced fibrinogen deposition and it is therefore hypothesized that ECM-446 
associated fibrinogen represents an adherence target during the initial stage of host 447 
colonisation. In support of this hypothesis, it has been demonstrated previously that two T. 448 
medium-like treponemal strains, UB1467 and UB1090, isolated from a bovine and an ovine 449 
DD lesion, and a T. pedis-like strain, UB1466, isolated from an ovine DD lesion, were all 450 
capable of adhering to immobilised fibrinogen (83). Thus, adhesin-mediated treponemal 451 
adherence to the host via such interactions may be central to the treponemal infection, in 452 
which abrasive trauma may be necessary point of entry.  453 
Soluble host proteins, including plasma fibrinogen, may act as a diffuse peptide nutrient 454 
source within inflamed tissues. However, fibrinogen additionally plays a direct role in 455 
antimicrobial host defence. Firstly, thrombin-catalysed conversion to insoluble fibrin clots 456 
leads to the formation of a structural protective barrier capable of containing bacteria and 457 
preventing dissemination (84). Secondly, this conversion to thrombin leads to the release of 458 
potent chemotactic elements, including fibrinopeptide B, which drives an influx of phagocytes 459 
(85). Amongst the treponemal OMPs, Chymotrypsin-Like Protease (CTLP) from T. denticola 460 
and Tp0751 (Pallysilin) from T. pallidum subs. pallidum, are both capable of adhering to 461 
fibrinogen whilst additionally exhibiting fibrinogenolytic protease activity, with important 462 
deleterious consequences for platelet homeostasis and clot formation (29, 86). BDD lesions 463 
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tend to bleed readily upon palpation (87), and a disturbance in the coagulation pathway 464 
arising from treponemal fibrinogen targeting is suspected. The interactions observed 465 
between the recombinant proteins and specific chains of the fibrinogen molecule identified 466 
in the present study may support this hypothesis, since the four recombinant proteins 467 
exhibited the capacity to adhere to all three fibrinogen chains or the beta and gamma chains 468 
only. Crucially, platelet aggregation is dependent on the binding of platelet membrane 469 
glycoprotein IIa/IIIb to the fibrinogen Aα and γ chain (88) and previous studies have identified 470 
selective fibrinogen chain targeting by pathogenic OMPs. For instance, targeting of the γ chain 471 
of fibrinogen has been previously reported by S. aureus clumping factor A (89), leading to 472 
disturbances in platelet aggregation, fibrin clot formation and platelet-mediated clot 473 
retraction (90).   474 
The mechanisms that underpin the observed interactions with fibrinogen are unknown and 475 
require further investigation. Further studies, using gene mutagenesis and critical binding 476 
domain mapping, are required to fully understand the molecular basis for these interactions. 477 
It is noteworthy that these proteins appear to adhere to a number of other ECM components, 478 
demonstrating the apparent multi-specificity of these putative treponemal adhesins. 479 
Although we have not yet explored these interactions further, this suggests that these 480 
molecules may be functionally similar to a number of other spirochaetal OMPs capable of 481 
adhering to multiple ligands, including Tp0751 (29) and OmpL1 (46).  This presumably 482 
represents an evolutionary adaptation that minimises bacterial surface immunogenicity 483 
whilst preserving adhesive function.  484 
Given the apparent importance of these putative OMPs to fibrinogen (and other ligands), and 485 
their potential roles in host colonisation and pathogenicity, we sought to assess their 486 
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immunogenic properties. Previous studies have shown that anti-adhesin antibodies, elicited 487 
by vaccination, have the potential to protect the host (91, 92) and it is hypothesised that 488 
blockade of these putative OMPs would impede host colonisation and/or virulence.  Previous 489 
attempts at designing a BDD vaccine have been limited to the use of treponemal whole-cell 490 
lysate ‘bacterin’ formulations of a single phylotype, and field trials have been disappointing 491 
(93). The subcutaneous vaccine formulation evaluated in the present study was designed 492 
specifically to induce an IgG response against putative treponemal fibrinogen-binding OMPs, 493 
which may be critical to host colonisation, yet exist as subdominant antigens with little or no 494 
immunogenic capacity in natural infection.  495 
Since recombinant protein antigens tend to be relatively weak antigens (94), aluminium 496 
hydroxide was employed as an adjuvant. Both an IgG1 and an IgG2 response to the putative 497 
OMP antigens was generated for the four proteins tested. Moreover, fold-change in the ELISA 498 
ODs generated for IgG1, relative to IgG2, was generally greater. Aluminium compounds are 499 
considered to be principally promotors of Th2 polarisation, at least in humans and mice (95, 500 
96), and may explain the IgG1 subclass bias observed in this study. A mixed IgG1/IgG2 or IgG1-501 
polarised host response may prove to be an important correlate of protection against an 502 
infection that is usually considered to induce a non-protective, yet robust, IgG2 response (68–503 
70). However, because a later study identified IgG1 as the predominant IgG subclass in cattle 504 
both naturally exposed to BDD and experimentally infected with BDD-associated treponemes 505 
(97), there exists considerable uncertainty of the nature of the bovine immune response in 506 
BDD and subsequently, its potential for manipulation.    507 
The four proteins evaluated were found to be immunogenic in both calves in the treatment 508 
group; only C5N99_10335 was found to be non-immunogenic in one of the two calves 509 
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immunised with this antigen, highlighting the heterogeneity of the immune response 510 
between vaccinees. Whether this apparent variation in immunogenicity has arisen from 511 
intrinsic differences in the molecular structures of these recombinant proteins, host-specific 512 
variations in immune response or potential contamination with endogenous endotoxin, has 513 
not been established. Moreover, whilst the immunogenic potential of these putative OMPs 514 
has been demonstrated here, neither the duration of the IgG response or its magnitude (in 515 
terms of absolute antibody titre) was established. Since the immunised calves were not 516 
assessed for post-vaccination susceptibility to BDD, it is unknown whether high titres of the 517 
IgG antibodies generated during this study correlate with protection against disease and 518 
future studies are warranted.  However, these data indicate successful B cell priming after the 519 
initial vaccination with a boost effect following the second vaccination, both of which are 520 
important characteristics of a vaccine component.   521 
Given the difficulties associated with the isolation, cultivation and purification of the BDD 522 
treponemes, the development of a vaccine against BDD has previously been substantially 523 
hindered.  This in silico approach to novel OMP identification overcomes the challenges of 524 
traditional vaccine design methods. To this end, we report on the identification and 525 
characterisation of four putative adhesins, selected from the sequenced genomes of T. 526 
medium and T. pedis phylogroups, two of the principle treponeme taxa associated with BDD. 527 
Further studies are justified to establish their value as BDD vaccine candidates.  528 
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Figure legends. 817 
Table 2. Each putative treponemal OMP was selected on the basis of predicted β-barrel 818 
topology by at least one of the β-barrel prediction programs. The results generated by BOMP, 819 
PRED-TMBB, TMBETA-NET and SPAAN were interpreted in accordance with default cut-off 820 
values. All four CDS features were predicted to share domain homology with known bacterial 821 
OMPs.  822 
Fig. 1. The four putative β barrel-outer membrane proteins (a-d) were structurally modelled 823 
using I-TASSER.  A lateral view of the top-ranking ribbon model, as determined by the C-score, 824 
is shown, with β-sheet depicted in blue and α-helix depicted in red.  825 
Table 3. The amino acid sequence of each putative OMP was submitted to I-TASSER for 3D 826 
structural modelling and Protein Databank (PDB) structural analogue detection. 1C-Score: A 827 
confidence score for estimating the quality of predicted models. 828 
Fig. 2. Gel A, C5N99_02965; Gel B, C5N99_10335; Gel C, DYQ05_06810. Gels A, B and C: 1, 829 
Wide-range MW marker (kDa); 2, unheated sample; 3, heated sample. The heat-modified 830 
(unfolded) forms of the proteins are distinguished from the unmodified (folded) forms by the 831 
addition of an asterisk (*). Panel C: lane between marker and sample contained a wash 832 
fraction and has been removed for brevity.    833 
Fig. 3. CD spectra of proteins encoded by a) C5N99_10335, b) C5N99_02965, c) DYQ05_06810, 834 
d) DYQ05_13425 and e) L. interrogans OmpL1 are shown. Far-UV CD spectra are presented as 835 
an average of three scans recorded from 190 to 260 nm. φ, molar ellipticity. 836 
 837 
38 
 
Fig. 4. Serological assessment of the IgG1 and IgG2 response to putative treponemal OMPs by 838 
ELISA. Error bars: standard error of the mean. Non-exp., Non-exposed; DD exp., digital 839 
dermatitis-exposed. Asterisks (*) indicates a significant difference in IgG seroreactivity relative 840 
to control sera as determined by Mann-Whitney U test (* P<0.05, ** P<0.005).  841 
Fig. 5. Immobilised ECM component binding screens of four putative β-barrel OMPs and the 842 
positive control protein (OmpL1). Bars represent the mean OD of three independent 843 
experiments. Error bars: standard error of the mean. Asterisks (*) indicate a significant 844 
difference in binding compared to the negative control protein, BSA, as determined by one-845 
way ANOVA and the Dunnett post-test (* P<0.05, **P<0.005, ***P<0.001). 846 
Fig. 6. Binding affinity curves of the four putative β-barrel OMPs to bovine fibrinogen. Graph 847 
A, putative OMPs from T. medium; Graph B, putative OMPs from T. pedis. Data points 848 
represent the mean OD of replicate readings. Error bars: standard error of the mean.  849 
Fig. 7. Specific binding interactions between the recombinant proteins and the α, β and γ 850 
chains of bovine fibrinogen, using monoclonal Anti-polyHistidine antibody as the probe.   851 
Fig 8. The serological IgG1 and IgG2 response to four treponemal putative OMPs was assessed 852 
in BDD-naïve calves (n=2). The mean OD of both immunised calves is shown. Error bars: 853 
standard error of the mean.  854 
 855 
 856 
 857 
 858 
 859 
 860 
 861 
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Figures and Tables.  862 
Table 1. Primers used to amply putative OMP genes for recombinant expression.  863 
Putative OMP 
locus tag 
Treponema 
phylogroup 
Primer sequence (5’-3’) 
Predicted 
band size (kb) 
Predicted 
mass (Kda) 
C5N99_10335 T. medium Forward: CACCGATGGGGTCGATTTTTCG 0.7 27.1 
  Reverse: CTACAGCTTAAAAGCGATCC   
C5N99_02965 T. medium Forward: CACCCAGGAAGAAGGAGCAGAGG 0.9 35.0 
  Reverse: AGAGATACCCATTAGTTGTTG   
DYQ05_13425 T. pedis Forward: CACCTTAAGCGATATTTCAGGCGATG 0.8 29.8 
  Reverse: TTACAGCTTCCATGCAATACC   
DYQ05_06810 T. pedis Forward: CACCGCAAAGACTATCGGTCTTAATTG 0.9 22.1 
  Reverse: TTAAAAATAAACTCTTAAACCCGC 0.6  
OmpL1 L. interrogans Forward: CACCAAAACATATGCAATTGTAGGATTTG 
 
NJKJ 
 
Reverse: GTTTTCGGAGTATTATCCGG 
0.8 31.0 
  Reverse: TTAGAGTTCGTGTTTATAACCG   
 864 
Table 2. Bioinformatic analysis of four putative treponemal OMPs.  865 
 
Putative OMP 
 
Treponema 
phylogroup 
 
Signal peptide 
cleavage site 
 
β-barrel  and adhesin prediction 
 
Homologous domain search 
BOMP  
PRED-
TMBB 
 
TMBETA-
NET 
 
SPAAN 
PDB Top Hit  
(% probability; 
E-value) 
Function Ref. 
C5N99_02965 T. medium 
YES (20/21; 
LSA/QE) YES NO YES YES 
OmpU  
(57.16; 120) 
OM Porin (58) 
C5N99_10335 T.medium 
YES (21/22; 
VFS/DG) YES YES YES YES 
OmpA  
(97.71; 6.1e-5) 
OM 
Porin/adhesin 
(59, 
60) 
DYQ05_13425 T. pedis 
YES (21/22; 
AFN/LS) NO YES YES YES 
OmpA  
(98.07; 4.9e-6) 
OM 
Porin/adhesin 
(59, 
60) 
DYQ05_06810 T. pedis 
YES (221/22; 
LSA/QT) YES YES YES YES 
OprF  
(97.32; 0.0014) 
OM porin (61) 
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 872 
Figure 1. Prediction of the treponemal putative OMP 3-dimensional structure 873 
 874 
 875 
Table 3. I-TASSER structural modelling of the treponemal OMPs: A summary of results.  876 
Putative OMP  C-score1 Predicted topology 
PDB Structural analog 
(bacterial species) 
Structural analog 
function 
Ref. 
C5N99_10335  3.98 8-stranded β-barrel 
OmpT  
(E. coli) 
Protease (62) 
C5N99_02965  2.73 β-solenoid barrel 
serine-rich repeat protein 
(Lactobacillus reuteriin) 
Cell adhesion (63) 
DYQ05_13425  4.07 8-stranded β-barrel 
OprG 
(Pseudomonas aeruginosa) 
Porin (64) 
DYQ05_06810  2.73 8-stranded β-barrel 
OmpA 
(E. coli) 
Porin (65) 
 877 
 878 
 879 
 880 
 881 
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Figure 2. Heat-modifiability of C5N99_10335, C5N99_02965 and DYQ05_06810. 882 
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 903 
Fig 3. Determination of protein fold state using far UV Circular Dichroism (CD).  904 
 905 
 906 
 907 
 908 
 909 
 910 
 911 
 912 
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Fig 4. Determination by ELISA of the serological response to four putative OMPs in BDD-913 
positive adult Holstein-Friesian dairy cattle.  914 
 915 
 916 
 917 
 918 
 919 
 920 
44 
 
Fig 5. Analysis of the attachment of treponemal putative OMPs to ECM components. 921 
 922 
 923 
 924 
 925 
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Fig. 6. Binding affinity curves of the four putative β-barrel OMPs to bovine fibrinogen. 926 
 927 
 928 
Table 4. Binding interactions between the putative recombinant OMPs and bovine 929 
fibrinogen.  930 
 931 
OMP  Dissociation Constant (KD)  
C5N99_02965  0.3370 ±0.09753  
DYQ05_13425  0.7180 ±0.08743  
DYQ05_16810  1.024 ±0.2946  
OmpL1  0.3669 ± 0.04328 (0.223  ±0.063 (47)) 
) 
 
 932 
Fig. 7. Far western blotting analysis of the treponemal recombinant OMP-Bovine fibrinogen 933 
binding interactions.   934 
 935 
 936 
46 
 
Fig. 8. Serological IgG1 and IgG2 response to immunisation with four recombinant treponemal 937 
putative OMPs.  938 
 939 
 940 
 941 
Table 5. Fold-change in calf seroreactivity to the inoculated treponemal recombinant putative 942 
OMPs.    943 
 944 
Antigen  
IgG1 Fold-change  
(day 28 post-immunisation) 
 IgG2 Fold-change 
 (day 28 post immunisation) 
C5N99_10335  2.37  1.66 
66 C5N99_02965  4.34  3.58 
DYQ05_13425  7.44  9.10 
DYQ05_06810  5.42  6.00 
 945 
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